aid: aulos name: Aulos image: https://aulos.b-cdn.net/wp-content/uploads/2021/12/Aulos-Bio-logo-for-social-share-300-x-300.jpg description: 'Aulos Bioscience develops an immune‑activating antibody therapeutic, imneskibart (AU‑007), that binds the interleukin‑2 region interacting with the CD25 receptor to shift IL‑2 activity toward immune activation and away from suppression. The company is advancing this investigational product in Phase 1/2 trials for patients with unresectable locally advanced or metastatic solid‑tumor cancers, including melanoma and renal cell carcinoma. Its focus is on delivering a novel IL‑2‑based therapy to cancer patients and the clinical research community.' url: https://raw.githubusercontent.com/api-evangelist/aulos/refs/heads/main/apis.yml x-type: company x-source: harvest:secondary-market x-tier: profiled x-tier-reason: enrichment pass 2026-09-26 (modular-v1; was harvest) specificationVersion: '0.20' created: '2026-09-26' modified: '2026-10-06' tags: - Oncology - Biopharma - Antibody Therapeutics - IL-2 Therapeutics - Clinical Trials maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - url: https://aulosbio.com/feed/ type: BlogRSS - type: Hosts url: hosts/aulos-hosts.yml - type: Leadership url: https://aulosbio.com/about-us/leadership/ - type: DomainSecurity url: security/aulos-domain-security.yml - type: Website url: https://aulosbio.com/ - type: Documentation url: https://aulosbio.com/about-us/ - type: TermsOfService url: https://aulosbio.com/terms-of-use/ - type: PrivacyPolicy url: https://aulosbio.com/privacy-policy/ - type: Contact url: https://aulosbio.com/contact/ - type: Careers url: https://aulosbio.com/careers/ - type: Newsroom url: https://aulosbio.com/newsroom/ apis: [] x-coverage: state: unreadable reason: no-machine-readable-spec detail: The provider's website offers only HTML documentation with no machine‑readable OpenAPI, AsyncAPI, GraphQL, gRPC or WSDL contracts. evidence: - url: https://aulosbio.com status: 200 checked: 2026-09-26 x-enrichment: date: '2026-09-26' status: enriched artifacts_added: 5 pass: modular-v1 engine: identity=local,contract=local,surfaces=local,docs=local